Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07249528 · ClinicalTrials.gov registry record
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 20
- Enrollment target
NCT07249528: Recruiting study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07249528 is a clinical trial that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07249528 is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to collect voice recordings and nervous system (neurologic) assessments from people with non-Hodgkin lymphoma (NHL) or multiple myeloma (MM) who are receiving standard treatment with CAR T-cell therapy. Researchers will study whether these voice recordings and assessments are a practical (feasible) way to monitor for immune effector cell-associated neurotoxicity syndrome (ICANS). Feasibility will be measured by tracking how many participants join the study and complete the assessments.
Interventions
- DIAGNOSTIC_TEST Audio Tasks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-04-17 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07249528
The ClinicalTrials.gov registry entry for NCT07249528 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Audio Tasks is the first listed.
NCT07249528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07249528 about?
NCT07249528 is a clinical study titled "A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy". The purpose of this study is to collect voice recordings and nervous system (neurologic) assessments from people with non-Hodgkin lymphoma (NHL) or multiple myeloma (MM) who are receiving standard treatment with CAR T-cell therapy. Researchers will study whether these voice recordings and assessment...
What is the current status of trial NCT07249528?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2026-04-17. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07249528?
The interventions under investigation include: Audio Tasks (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07249528?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.